Ocular fundus lesions in systemic lupus erythematosus model mice

Japanese Journal of Ophthalmology

Volumn 42, Issue 5, 1998, Pages 345-351

  Nakamura, Atsuo ^a   Yokoyama, Toshiyuki ^a   Kodera, Sanki ^a   Zhang, Danqing ^a   Hirose, Sachiko ^a   Shirai, Toshikazu ^a   Kanai, Atsushi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

(NZWXBXSB) F1 mice; Ocular fundus lesions; Systemic lupus erythematosus; Yaa gene

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHORIORETINOPATHY; EYE FUNDUS; EYE INJURY; FEMALE; GENE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DETACHMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; CHOROID DISEASES; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; FUNDUS OCULI; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED NZB; PIGMENT EPITHELIUM OF EYE; RETINAL DETACHMENT; RETINAL DISEASES; RETINAL VESSELS;

EID: 0031766043     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(98)00023-9     Document Type: Article

References (45)

1. Yoshimoto H, Yanagita Y. Ocular manifestation of systemic lupus erythematosus (SLE). Rinsho Ganka (Jpn J Clin Ophthalmol) 1971;25:1841-5.
2. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972;56:800-4.
3. Copperto J, Lessels S. Retinopathy in systemic lupus erythematosus. Arch Ophthalmol 1977;95:794-7.
4. Wong K, Ai E, Jones JV, Young D. Visual loss as the initial symptom of systemic lupus erythematosus. Am J Ophthalmol 1981;92:238-44.
5. Imaizumi H, Kimura S, Takeda M, Tanabe H, Miyabe S. Funduscopic findings in SLE (systemic lupus erythematosus). Nihon Ganka Kiyo (Folia Ophthalmol Jpn) 1986;37:389-99.
6. Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy patterns, associations, and prognosis. Arthritis Rheum 1988;37:1105-10.
7. Matsuo T, Nakayama T, Koyama T, Matsuo N. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica (Basel) 1987; 195:97-102.
8. Tamura K, Sugime M, Tamiya M, Nakai Y. A case of bilateral bullous retinal detachment with systemic lupus erythematosus. Nihon Ganka Kiyo (Folia Ophthalmol Jpn) 1987;38:790-7.
9. Jabs DA, Hanneken AM, Schachat AP, Fine SL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1988;106:230-4.
10. Takahashi A, Mizukawa J, Okisaka S. A case report of choroidopathy with bullous detachment associated with SLE. Nihon Ganka Kiyo (Folia Ophthalmol Jpn) 1989;40:1081-5.
11. Kawaguchi Y, Hara M, Hirose T, et al. A case of systemic lupus erythematosus complicated with multifocal posterior pigment epitheliopathy. Official J Rheumatism Assoc 1990; 30:396-402.
12. Suzuki R, Senoh T, Yagi K. Two cases of retinal pigment epitheliopathy with systemic lupus erythematosus. Ganka Rinsho Iho (Jpn Rev Clin Ophthalmol) 1992;86:2492-5.
13. Tamiya R, Takahashi K, Matsubara T, Fukushima I. Multifocal posterior pigment epitheliopathy in a case of lupus nephritis. Rinsho Ganka (Jpn J Clin Ophthalmol) 1994;48:1757-63.
14. Okada J, Kadoya A. SLE and antiphospholipid syndrome. Igaku no Ayumi (J of Clin Exper Med) 1996;176:300-4.
15. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GRV. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the primary antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-61.
16. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591-609.
17. Hughes GRV, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-89.
18. Love PE, Santro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
19. Bielshowsky M, Helyer BJ, Howie JB. Spontaneous haemolytic anemia in mice of the NZB/BL strain. Proc Univ Otago Med Sch 1959;37:9-11.
20. Helyer BJ, Howie JB. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 1963;197:197.
21. Howie JB, Helyer BJ. The immunology and pathology of NZB mice. Adv Immunol 1968;9:215-66.
22. Braverman IM. Study of autoimmune disease in New Zealand mice. I. Genetic features and natural history of NZB, NZY, and NZW strains and NZB/NZW hybrids. J Invest Dermatol 1968;50:483-99.
23. Chused TM, Moutsopoulos HM, Sharrow SO, Hansen CT, Morse HC. Mechanism of autoimmune disease in New Zealand Black mice. In: Rose NR, et al, eds. Genetic control of autoimmune disease. New York: North-Holland, Elsevier, 1978:171-91.
24. Shirai T, Hirose S, Okada T, Nishimura H. Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains. In: Rihova B, Vetvicka V, eds. Immunological disorders in mice. Boca Raton: CRC Press, 1991:95-163.
25. Murphy ED. Lymphoproliferation (lpr) and other single-locus models for murine lupus. In: Gershuwin ME et al, eds. Immunologic defects in laboratory animals 2. New York: Plenum, 1981:143-173.
26. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1984;133:227-33.
27. Murphy ED, Roths JB. Autoimmunity and lymphoproliferation; induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose NR, et al, eds. Genetic control of autoimmune disease. North Holland/New York: Elsevier, 1987;207-21.
28. Shirai T, Hirose S, Sekigawa I, Okada T, Sato H. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice. J Rheumatol 1987; 14:11-19.
29. Oyaizu N, Yasumizu R, Miyama-Inaba M, Nomura S, Yoshida H, Miyawaki S. (NZWXBXSB) F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-22.
30. Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Sumida T, Yoshida S. Anticardiolipin antibodies in NZWXBXSB F1 mice. A model of antiphospholipid syndrome. J Immunol 1992;149:1063-8.
31. Hang LM, Izui S, Dixon FJ. (NZWXBXSB) F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 1981;154:216-21.
32. Yoshida H, Fujiwara H, Fujiwara T, Ikehara S, Hamashima Y. Quantitative analysis of myocardial infarction in (NZWXBXSB) F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am J Pathol 1987;129:477-85.
33. Knight JG, Adams DD, Purves HD. The genetic contribution of the NZW mouse to the renal disease of the NZBXNZW hybrid. Clin Exp Immunol 1977;28:352-8.
34. Shirai T. The genetic basis of autoimmunity in murine lupus. Immunol Today 1982;3:187-94.
35. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
36. Izui S, Masuda K, Yoshida H. Acute SLE in F1 hybrids between SB/Le and NZW mice: prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice. J Immunol 1984;132:701-4.
37. Izui S, Higaki M, Morrow D, Merino R. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZWXC57BL/6) F1 male mice, but not in C57BL/ 6 male mice. Eur J Immunol 1988;18:911-5.
38. Merino R, Fossat L, Lacou M, Lemoine R, Higaki M, Izui S. H-2 linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur J Immunol 1992;22:295-99.
39. Kawano H, Abe M, Zhang D, Fujimori M, Hirose S, Shirai T. Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZWXBXSB) F1 Mice. Clin Immunol Immunopathol 1992;65:308-14.
40. Hirose S, Ueda G, Nogchi K, et al. Requirement of H-2 heterozygosity for autoimmunity in (NZBXNZW) F1 hybrid mice. Eur J Immunol 1986;16:1631-3.
41. Hirose S, Kinoshita K, Nozawa S, Nishimura H, Shirai T. Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice. Int Immunol 1990; 2:1091-5.
42. Hirose S, Nagasawa R, Sekikawa I, et al. Enhancing effect of H-2 linked NZW gene(s) on the autoimmune traits of (NZBXNZW) F1 mice. J Exp Med 1983;158:228-33.
43. Pulido JS, Ward LM, Fishman GA, Goodwin JA, Froelich CJ, Sanghvi JP. Antiphospholipid antibodies associated with retinal vascular disease. Retina 1987;7:215-8.
44. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989;96:896-904.
45. Snyers B, Lambert M, Hardy JP. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 1990;10:255-60.